Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

CDC CFS Publications

This is a compilation of publications by the CDC CFS Public Health Research Program from 2006 to present. This section includes only publications involving the CDC CFS research group.

2006 Publications

  • Aslakson E, Vollmer-Conna U, White PD. The validity of an empirical delineation of heterogeneity of chronic unexplained fatigue. Pharmacogenomics 7:365-373, 2006.
  • Broderick G, Craddock RC, Whistler T, Taylor R, Klimas N, Unger ER. Identifying illness parameters in fatiguing syndromes using classical projection methods. Pharmacogenomics 7:407-419, 2006.
  • Cameron B, Bharadwaj M, Burrows J, Fazou C, Wakefield D, Hickie I, Ffench R, Khanna R, Lloyd A. Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load. J Infect Dis 193:664-671, 2006.
  • Capuron L, Welberg L, Heim C, Wagner D, Solomon L, Papanicolaou DA, Craddock RC, Miller AH, Reeves WC. Cognitive dysfunction related to subjective report of mental fatigue in patients with chronic fatigue syndrome. Neuropsychopharmacology 31:1777-1784, 2006.
  • Carmel L, Efroni S, White PD, Aslakson E, Vollmer-Conna U, Rajeevan M. Gene expression profile of empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics 7:375-386, 2006.
  • Craddock RC, Taylor R, Broderick G, Whistler T, Klimas N, Unger ER. Exploration of statistical dependence between illness parameters using the entropy correlation coefficient. Pharmacogenomics 7:421-428, 2006.
  • Davis Rl, Khoury MJ. A public health approach to pharmacogenomics and gene-based diagnostic tests. Pharmacogenomics 7:331-337, 2006.
  • Demitrack MA. Clinical methodology and its implications for the study of therapeutic interventions for chronic fatigue syndrome: a commentary. Pharmacogenomics 7:521-528, 2006.
  • Du P, Kibbe WA, Lin JMS. Improved peak detection in mass spectrum by incorporating continuous wavelet transform-based pattern matching. Bioinformatics. 22:2059-2065, 2006.
  • Fang H, Xie Q, Boneva R, Fostel J, Perkins R, Tong W. Gene expression profile exploration of a large dataset on chronic fatigue syndrome. Pharmacogenomics 7:429-440, 2006.
  • Fostel J, Boneva R, Lloyd A. Exploration of the gene expression correlates of chronic unexplained fatigue using factor analysis. Pharmacogenomics 7:441-454, 2006.
  • Goertzel BN, Pennachin C, Coelho LD, Gurbaxani B, Maloney EM, Jones JF. Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome. Pharmacogenomics 7:475-483, 2006.
  • Goertzel BN, Pennachin C, Souza Coelho L, Maloney EM, Jones JF, Gurbaxani B. Allostatic load is associated with symptoms in CFS patients. Pharmacogenomics 7:485-494, 2006.
  • Gupta S, Aslakson E, Vernon SD. Identifying a central nervous system perturbation that explains peripheral hypocortisolism by modeling the HPA axis. Proceedings 19th IEEE Symposium on Computer-Based Medical Systems (CBMS'06) 550-554.
  • Gurbaxani B, Jones JF, Goertzel BN, Maloney EM. Linear data mining on the Wichita clinical matrix: pitfalls and limitations. Pharmacogenomics 7:455-465, 2006.
  • Heim C, Wagner D, Maloney E, Papanicolaou DA, Solomon L, Jones JF, Unger ER, Reeves WC. Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Archives of General Psychiatry 63:1258-1266, 2006.
  • Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, Reeves WC, Lloyd A. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study. Br Med J 333:575-580, 2006
  • Lin SM, Devakumar J, Kibbe WA. Improved prediction of treatment response using microarrays and existing biological knowledge. Pharmacogenomics 7:495-501, 2006.
  • Maloney EM, Gurbaxani BM, Jones JF, Souza Coelho L, Pennachin C, Goertzel BN. Chronic fatigue syndrome and high allostatic load. Pharmacogenomics 7:467-473, 2006.
  • Malyarenko DI, Cooke WE, Tracy ER, Drake RR, Shin S, Semmes OJ, Sasinowski M, Manos DM. Resampling and deconvolution of linear time of flight records for enhanced protein profiling. Rapid Communications in Mass Spectrometry. 20:1670-1678, 2006.
  • Nater UM, Wagner D, Solomon L, Jones JF, Unger ER, Papanicolaou DA, Reeves WC, Heim C. Coping styles in people with chronic fatigue syndrome identified from the general population of Wichita, KS. J Psychosomatic Res 60:567-573, 2006.
  • Reeves WC, Heim C, Beck M, Maloney E, Solomon Youngblood L, Unger ER, Decker MJ, Jones JF, Rye DB. Sleep characteristics of persons with chronic fatigue syndrome and non-fatigued controls: results from a population-based study. BMC Neurology 6:41, 2006.
  • Shoemaker J. Statistical challenges with gene expression studies. Pharmacogenomics 7:511-519, 2006.
  • Smith AK, White PD, Aslakson E, Vollmer-Conna U, Rajeevan MS. Polymorphisms in genes regulating HPA axis associated with empirically delineated classes of unexplained chronic fatigue. Pharmacogenomics 7:387-394, 2006.
  • Vernon SD, Nicholson A, Rajeevan M, Dimulescu I, Cameron B, Whistler T, Lloyd A. Correlation of psycho-neuroendocrine-immune (PNI) gene expression with symptoms of acute infectious mononucleosis. Molecular Brain Research. 1068:1-6, 2006.
  • Vernon SD, Reeves WC. The challenge of integrating disparate high-content data: epidemiologic, clinical, and laboratory data collected during an in-hospital study of chronic fatigue syndrome. Pharmacogenomics 7:345-354, 2006.
  • Vernon SD, Whistler T, Aslakson E, Reeves WC. Challenges for molecular profiling of chronic fatigue syndrome. Pharmacogenomics 7:211-218, 2006.
  • Vernon SD, Whistler T, Cameron B, Hickie I, Reeves WC, Lloyd A. Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus. BMC Infectious Diseases 6:15, 2006.
  • Vollmer-Conna U, Aslakson E, White PD. An empirical delineation of the heterogeneity of chronic unexplained fatigue. Pharmacogenomics 7:355-364, 2006.
  • Waltman P, Peearlman A, Mishra B. Interpreter of maladies: redescription mining applied to biomedical data analysis. Pharmacogenomics 7:503-509, 2006.
  • Whistler T, Taylor R, Craddock RC, Broderick G, Klimas N, Unger ER. Gene expression correlates of unexplained fatigue. Pharmacogenomics 7:395-405, 2006.
  • Witkowski JA. The postgenomic era and complex disease. Pharmacogenomics 7:341-343, 2006.

2007 Publications

Pages in this Section

CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    TTY: (888) 232-6348
  • Contact CDC-INFO The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC-INFO